Skip to content

Quality of Life and Sjögren Syndrome

Quality of Life in a Portuguese Population With Primary Sjögren Syndrome

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03578900
Enrollment
289
Registered
2018-07-06
Start date
2013-01-01
Completion date
2016-12-31
Last updated
2018-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyposalivation, Quality of Life, Sjogren's Syndrome, Xerostomia

Keywords

Xerostomia, Hyposalivation, Quality of Life, Sjogren's Syndrome

Brief summary

The aims of this study are: To compare salivary pH changes and stimulation efficacy of two different Gustatory Stimulants of Salivation (GSSS) in patients with Primary Sjögren Syndrome (PSS); To evaluate Primary Sjögren syndrome (PSS) impact and gustatory stimulants of salivary secretion (GSSS) on oral health related quality of life measured by a Portuguese version of Oral Health Impact Profile-14 (OHIP-14) and specific Xerostomia assessment questionnaires. The Products to be used are the Xeros® Dentaid system and a citric based mouthwash.

Interventions

DRUGXeros
DRUGCitric Acid based Mouthwash

Sponsors

University of Lisbon
CollaboratorOTHER
Portuguese Institute of Rheumatology
CollaboratorUNKNOWN
Dentaid SL
CollaboratorINDUSTRY
Grupo de Investigação em Bioquímica e Biologia Oral
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* unstimulated whole saliva secretion rate \< 0.1 ml/min * stimulated whole saliva secretion rate \> 0.2 ml/min * above 18 years of age * Primary Sjogren Syndrome diagnostic according to the European-American Consensus Group

Exclusion criteria

* wearer of complete dental prosthesis * those who were pregnant or lactating * non-speakers of Portuguese.

Design outcomes

Primary

MeasureTime frameDescription
Time of GSSS induced pH drop below 4.520 minutesOn the day that the system is attributed the subject is asked to use one of the products and saliva is collected. pH variation is determined at fixed intervals during 20 minutes. Time in which salivary pH is below 4.5 is calculated as well as the number needed to treat and the absolute risk reduction.
Overall and sub domains scores for each questionnaire15 daysBefore and after usage of both products at home, the Summated Xerostomia Inventory-5 (range 0 to 15) to measure subjective feeling of dry mouth, Oral Health Impact Profile-14 (range 0 to 56) to measure quality of life perception related to the oral cavity. This last questionnaire is further divided into 7 subdomains: functional limitation, physical pain, psychological discomfort, physical disability, psychologic disability, social disability and handicap each ranging from 0 to 14. In both questionnaires the total score is the result of the sum of the individual scores in each question. In both questionnaires the higher the score the worse the outcome. The before and after scores obtained are then compared.

Secondary

MeasureTime frameDescription
Salivary stimulant induced salivary flow20 minutesWhile using one of the two products saliva is collected, weighed and salivary flow is determined at fixed times during 20 minutes.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026